Get the Stockscreener App
384.93
0.34%
1.83
Overview
News
Price History
Option Chain
Financials
Why HCA Down?
Discussions
Forecast
Dividend History
Hca Healthcare Inc stock is traded at $384.93, with a volume of 51,253.
It is up +0.34% in the last 24 hours and up +0.79% over the past month.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
See More
Previous Close:
$383.10
Open:
$384.09
24h Volume:
51,253
Relative Volume:
0.03
Market Cap:
$87.79B
Revenue:
$71.59B
Net Income/Loss:
$5.78B
P/E Ratio:
17.12
EPS:
22.49
Net Cash Flow:
$4.95B
1W Performance:
+1.42%
1M Performance:
+0.79%
6M Performance:
+28.08%
1Y Performance:
+21.99%
1-Day Range:
$381.04
$386.00
1-Week Range:
$369.89
$388.59
52-Week Range:
$289.98
$417.14
Hca Healthcare Inc Stock (HCA) Company Profile
Name
Hca Healthcare Inc
Sector
Industry
Phone
(615) 344-9551
Address
ONE PARK PLZ, NASHVILLE, TN
Compare HCA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
384.82 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
28.69 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
177.21 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
122.70 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
182.13 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-25-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Nov-22-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-03-24 | Initiated | Morgan Stanley | Equal-Weight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-04-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-19-23 | Resumed | JP Morgan | Neutral |
| Jul-06-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-29-22 | Initiated | Wells Fargo | Equal Weight |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-24-21 | Initiated | UBS | Buy |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-13-21 | Resumed | Citigroup | Neutral |
| Apr-26-21 | Downgrade | Citigroup | Buy → Neutral |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-14-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-06-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-10-19 | Upgrade | Goldman | Neutral → Buy |
| Apr-23-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Nov-16-18 | Initiated | UBS | Buy |
| Mar-23-18 | Resumed | Mizuho | Buy |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Jan-03-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Dec-20-17 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-12-17 | Upgrade | Citigroup | Neutral → Buy |
| Nov-30-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-06-17 | Reiterated | Citigroup | Neutral |
| Nov-01-17 | Reiterated | Mizuho | Buy |
| Jul-26-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-28-17 | Initiated | Argus | Buy |
View All
Hca Healthcare Inc Stock (HCA) Latest News
NC Panel Rejects HCA Unit's Appeal Over Rival Project Award - Law360
Morgan Stanley Upgrades HCA Healthcare (HCA) PT to $410, Keeps Equal Weight Rating - MSN
HCA Healthcare Defeats Whistleblowers’ Privacy Fraud Lawsuit - Bloomberg Law News
Will Regulatory Concerns Take a Backseat to Tariff Implications for HCA Healthcare (HCA)? - Insider Monkey
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term - Yahoo Finance
Healthcare Worker's Wage Collective 'Amorphous,' HCA Says - Law360
HCA Healthcare stock price target reiterated at $444 by Cantor Fitzgerald - Investing.com
HCA Healthcare Climbs 3.6% After Key Trading Signal - Benzinga
HCA Healthcare Awards of Distinction at EIRMC - Idaho State Journal
The Boss: Cindy Bergmeier is always up to explore new places - The Business Journals
Why HCA Healthcare, Inc. (NYSE:HCA) Could Be Worth Watching - Yahoo Finance
When the Price of (HCA) Talks, People Listen - news.stocktradersdaily.com
HCA Healthcare, Inc. (NYSE:HCA) Q2 2024 Earnings Call Transcript - MSN
HCA Florida Memorial opens head and neck practice - Jacksonville Daily Record
Samuel Hazen: 100 Most Influential People in Healthcare 2024 - Modern Healthcare
HCA Healthcare Establishes $4 Billion Commercial Paper Program - Global Legal Chronicle
8 Best Inexpensive Stocks to Buy Right Now - Insider Monkey
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Columbia Hospital Corporation - Britannica
HCA Healthcare Insiders Sold US$12m Of Shares Suggesting Hesitancy - Yahoo Finance
HCA Healthcare (HCA) Launches $4 Billion Commercial Paper Progra - GuruFocus
HCA Healthcare Launches $4 Billion Commercial Paper Program - TipRanks
HCA Healthcare (HCA) Stock Declines Over 1.2%, Continuing a Short-Term Downtrend - Daily Chhattisgarh News
HCA FLORIDA MEMORIAL HOSPITAL RECEIVES COMPREHENSIVE STROKE CENTER CERTIFICATION FROM DNV - southfloridahospitalnews.com
HCA Healthcare (NYSE:HCA) Given New $410.00 Price Target at Morgan Stanley - Defense World
HCA Healthcare (HCA): Analyst Insights and Market Prospects | HC - GuruFocus
Is HCA Healthcare Stock Outperforming the Nasdaq? - MSN
HCA, Tenet upgraded at Wells Fargo on receding policy risks for hospitals - MSN
HCA Healthcare Inc (HCA) Trading Down 3.52% on Jun 9 - GuruFocus
HCA Healthcare (HCA) Price Target Raised by Morgan Stanley | HCA Stock News - GuruFocus
Celebration showcases new HCA Florida Sarasota Doctors Hospital free-standing ER in Venice - Sarasota Herald-Tribune
HCA Healthcare Options Trading: A Deep Dive into Market Sentiment - Nasdaq
Sammie Mosier: Most Influential Clinical Executives 2025 - Modern Healthcare
HCA Healthcare (HCA) Price Target Increased to $410 by Morgan St - GuruFocus
Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Morgan Stanley Adjusts Price Target on HCA Healthcare to $410 rom $355, Maintains Equalweight Rating - marketscreener.com
HCA Florida Healthcare doctor discusses what it means to be a trauma center, summer safety - WEAR-TV
Why HCA Healthcare (HCA) is a Top Momentum Stock for the Long-Term - sharewise
HCA Healthcare, Inc. (NYSE:HCA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Is HCA Healthcare Stock Outperforming The Nasdaq? - Barchart.com
HCA Worker Wants Collective Status In Time-Rounding Suit - Law360
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock - Yahoo Finance
Leerink Partners Adjusts HCA Healthcare Price Target to $420 From $390 - marketscreener.com
HCA Healthcare (NYSE:HCA) Given New $416.00 Price Target at Barclays - Defense World
Barclays Raises Price Target for HCA Healthcare (HCA) | HCA Stock News - GuruFocus
Trend Tracker for (HCA) - news.stocktradersdaily.com
Barclays Adjusts Price Target for HCA Healthcare to $416 | HCA S - GuruFocus
Barclays Adjusts HCA Healthcare Price Target to $416 From $366, Maintains Overweight Rating - marketscreener.com
Barclays Adjusts Price Target for HCA Healthcare to $416 | HCA Stock News - GuruFocus
Wells Fargo Upgrades HCA Healthcare (BMV:HCA) - Nasdaq
Hca Healthcare Inc Stock (HCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):